MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt · Delayed Price · Currency is EGP 794.00
+0.12 (0.02%)
At close: Aug 5, 2026
MINAPHARM Pharmaceuticals Financials Overview
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,438 | 6,438 | 5,600 | 3,892 | 3,621 | 3,005 |
Revenue Growth | 14.97% | 14.97% | 43.87% | 7.50% | 20.47% | 27.29% |
Gross Profit Gross Profit Growth | 2,300 | 2,300 | 1,932 | 1,252 | 1,496 | 1,185 |
Operating Income Operating Income Growth | 1,019 | 1,019 | 933.85 | 374.66 | 964.74 | 753.96 |
Net Income Net Income Growth | 6.62 | 6.62 | 128.22 | -55.39 | 589.91 | 447.71 |
Earnings Per Share EPS Growth | 0.60 | 0.60 | 11.59 | -5.01 | 51.41 | 36.42 |
EPS Growth | -94.84% | -94.84% | - | - | 41.17% | 56.95% |
| Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Bio Production Bio Production Growth | 3,281 | 3,281 | 2,848 |
Drug Production Drug Production Growth | 1,157 | 1,157 | 1,042 |
Other Supplies Other Supplies Growth | 2,000 | 2,000 | 1,709 |
Commercial Sales Commercial Sales Growth | - | - | 65.62 |
Total Total Growth | 6,438 | 6,438 | 5,665 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,430 | 3,430 | 2,890 | 1,918 | 1,694 | 981.94 |
Total Debt Total Debt Growth | 4,540 | 4,540 | 5,578 | 3,806 | 2,433 | 1,248 |
Net Cash (Debt) Net Cash Growth | -1,110 | -1,110 | -2,688 | -1,889 | -739.64 | -266.46 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -100.33 | -100.33 | -242.93 | -170.70 | -64.46 | -21.67 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 464.81 | 464.81 | 221.51 | 102.34 | 561.77 | 207.28 |
Capital Expenditures CapEx Growth | -787.8 | -787.8 | -918.96 | -1,395 | -1,160 | -387.87 |
Free Cash Flow Free Cash Flow Growth | -322.99 | -322.99 | -697.45 | -1,292 | -598.45 | -180.6 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 35.73% | 35.73% | 34.50% | 32.16% | 41.33% | 39.44% |
Operating Margin | 15.82% | 15.82% | 16.68% | 9.63% | 26.65% | 25.09% |
Pretax Margin | 3.32% | 3.32% | 4.99% | 0.85% | 24.32% | 22.24% |
Profit Margin | 0.10% | 0.10% | 2.29% | -1.42% | 16.29% | 14.90% |
FCF Margin | -5.02% | -5.02% | -12.46% | -33.21% | -16.53% | -6.01% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.500 | - | 2.500 | 1.650 | 2.800 | 2.922 |
Dividend Per Share Growth | 0% | - | 51.52% | -41.07% | -4.17% | 8.21% |
Dividend Yield | 0.31% | - | 1.56% | 0.77% | 1.95% | 2.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 1413.70 | 621.84 | 14.01 | - | 3.09 | 2.91 |
PS Ratio | 1.45 | 0.64 | 0.32 | 0.62 | 0.50 | 0.43 |